Skip to main content

Table 4 The relationships between analyzed hemostatic parameters and cardiovascular disease (CVD) prevalence in patients with chronic kidney disease (CKD)

From: Indoxyl sulfate – the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease

 

vWF

TM

TF

TFPI

suPAR

uPA

tPA

sICAM

TF

−0.009

0.415

 

0.165

0.283

0.207

0.048

−0.039

NS

0.002

 

NS

0.044

NS

NS

NS

F1 + 2

−0.316

0.077

−0.007

−0.013

0.069

0.101

−0.287

0.068

0.023

NS

NS

NS

NS

NS

0.041

NS

TFPI

−0.165

0.556

0.165

 

0.417

0.210

0.067

0.104

NS

0.0001

NS

 

0.002

NS

NS

NS

PAP

0.324

0.302

0.063

0.342

0.346

0.176

0.192

0.317

0.020

0.031

NS

0.014

0.013

NS

NS

0.023

uPA

0.241

0.493

0.207

0.210

0.605

 

0.200

0.372

NS

0.0002

NS

NS

0.0001

 

NS

0.007

suPAR

0.479

0.639

0.283

0.417

 

0.605

0.258

0.525

0.0004

0.0001

0.044

0.002

 

0.0001

NS

0.0001

tPA

0.307

0.146

0.048

0.067

0.258

0.200

 

0.055

0.028

NS

NS

NS

NS

NS

 

NS

PAI-1

0.319

−0.184

−0.173

−0.009

0.028

0.113

0.363

0.039

0.022

NS

NS

NS

NS

NS

0.009

NS

vWF

 

0.194

−0.008

0.165

0.479

0.242

0.307

0.277

 

NS

NS

NS

0.0004

NS

0.028

0.049

TM

0.194

 

0.415

0.556

0.639

0.493

0.146

0.331

NS

 

0.002

0.0001

0.0001

0.0002

NS

0.017

sICAM-1

0.277

0.331

−0.039

0.104

0.525

0.372

0.055

 

0.049

0.017

NS

NS

0.0001

0.007

NS

 

sVCAM-1

0.288

0.598

0.282

0.298

0.656

0.407

0.057

0.654

0.040

0.0001

0.044

0.033

0.0001

0.003

NS

<0.0001

CVD

6.400

2.865

1.527

1.191

5.802

0.020

0.554

8.881

0.011

NS

NS

NS

0.016

NS

NS

0.003

  1. Results are shown as Spearman’s rank correlation coefficients (r) or bivariate logistic (χ 2) regression coefficient
  2. Abbreviations: TF tissue factor, F1 + 2 prothrombin fragments 1 + 2, TFPI tissue factor pathway inhibitor, PAP plasmin-α2-antiplasmin, uPA urinary plasminogen activator, suPAR soluble urokinase-type plasminogen activator receptor, tPA tissue plasminogen activator, PAI-1 plasminogen activator inhibitor-1, vWF von Willebrand Factor, TM thrombomodulin, sICAM-1 soluble intercellular adhesion molecule-1, sVCAM-1 soluble vascular cell adhesion molecule-1, CVD cardiovascular disease, NS non-significant